Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, July 10, 2024

Lucintel Forecasts Cardiovascular Device Market to Reach $116 Billion by 2030

According to the recent study the cardiovascular device market is projected to reach an estimated $116 billion by 2030 from $81 billion in 2023 at a CAGR of 5.2% from 2023 to 2030. Growth in this market is primarily driven by growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.

Browse 112 figures/charts and 84 tables in this 197-page report to understand trends, opportunity and forecast in cardiovascular device market by type (cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices), by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.

 Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.

Download sample by clicking on cardiovascular device market.

 North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.

Major players of cardiovascular device market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major cardiovascular device providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1 972.636.5056

Explore Our Latest Publications

Distributed Acoustic Sensing Market in Canada

Electric Saw Machine Market in Canada

Agricultural Input Market in Canada

Agrivoltaic Market in Canada

Animal Feed Amino Acid Market in Canada

Bottom Mounting Preset Thermostat Market in Canada

No comments:

Post a Comment